Yonhap Infomax NewsSep 10, 2025
Lotte Biologics marked a major milestone with the topping-out of its first Songdo plant, positioning itself as a new growth engine for the Lotte Group and targeting global CDMO leadership through expanded production and dual-site operations.
#YonhapInfomax #LotteBiologics #SongdoBioCampus #CDMO #AntibodyDrug #GrowthEngine #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=80979
Lotte Bio Touted as New Growth Engine Within Group, Says Shin Yu-yeol

Lotte Biologics marked a major milestone with the topping-out of its first Songdo plant, positioning itself as a new growth engine for the Lotte Group and targeting global CDMO leadership through expanded production and dual-site operations.

Yonhap Infomax
Yonhap Infomax NewsAug 25, 2025
Koas Co., a South Korean office furniture firm, soared to its daily trading limit after announcing the acquisition of biotech company Novelty Nobility, signaling a major pivot into drug development and the bio sector.
#YonhapInfomax #Koas #NoveltyNobility #Acquisition #AntibodyDrug #SharePriceSurge #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=78431
Office Furniture Firm Koas Hits Upper Limit on Acquisition of Drug Developer

Koas Co., a South Korean office furniture firm, soared to its daily trading limit after announcing the acquisition of biotech company Novelty Nobility, signaling a major pivot into drug development and the bio sector.

Yonhap Infomax
Yonhap Infomax NewsJun 19, 2025
Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343
Lotte Biologics Signs Antibody Drug Manufacturing Agreement with OTTIMO Pharma

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.

Yonhap Infomax